RARA
Gene Ontology Biological Process
- Sertoli cell fate commitment [IMP]
- apoptotic cell clearance [ISO]
- bone development [IGI]
- cellular response to estrogen stimulus [ISO]
- cellular response to lipopolysaccharide [IDA]
- cellular response to retinoic acid [ISO]
- chondroblast differentiation [IMP]
- embryonic camera-type eye development [IGI]
- face development [IGI]
- germ cell development [IMP]
- glandular epithelial cell development [IGI]
- growth plate cartilage development [IGI]
- intracellular estrogen receptor signaling pathway [ISO]
- limb development [IGI]
- male gonad development [ISO]
- multicellular organism growth [IGI]
- negative regulation of apoptotic process [IGI]
- negative regulation of cartilage development [IMP]
- negative regulation of cell differentiation [IMP]
- negative regulation of cell proliferation [ISO]
- negative regulation of gene expression [IGI]
- negative regulation of granulocyte differentiation [ISO]
- negative regulation of interferon-gamma production [ISO]
- negative regulation of transcription from RNA polymerase II promoter [IDA, IGI]
- negative regulation of transcription, DNA-templated [IDA, ISO]
- negative regulation of translation [ISO]
- negative regulation of translational initiation [IDA]
- negative regulation of tumor necrosis factor production [ISO]
- neural tube closure [IGI]
- outflow tract septum morphogenesis [IGI]
- positive regulation of ERK1 and ERK2 cascade [ISO]
- positive regulation of T-helper 2 cell differentiation [ISO]
- positive regulation of binding [ISO]
- positive regulation of cell cycle [ISO]
- positive regulation of cell proliferation [IGI, ISO]
- positive regulation of gene expression [IMP]
- positive regulation of interleukin-13 production [ISO]
- positive regulation of interleukin-4 production [ISO]
- positive regulation of interleukin-5 production [ISO]
- positive regulation of neuron differentiation [ISO]
- positive regulation of phosphatidylinositol 3-kinase signaling [ISO]
- positive regulation of protein kinase B signaling [ISO]
- positive regulation of transcription from RNA polymerase II promoter [IDA, IGI, ISO]
- positive regulation of transcription, DNA-templated [ISO]
- protein phosphorylation [ISO]
- regulation of apoptotic process [ISO]
- regulation of granulocyte differentiation [IMP]
- regulation of myelination [ISO]
- regulation of phosphatidylinositol 3-kinase activity [ISO]
- regulation of synaptic plasticity [ISO]
- regulation of transcription, DNA-templated [IDA]
- response to estradiol [ISO]
- response to ethanol [ISO]
- response to retinoic acid [IMP, ISO]
- retinoic acid receptor signaling pathway [IDA, ISO]
- signal transduction [ISO]
- spermatogenesis [IMP]
- trachea cartilage development [IMP]
- transcription from RNA polymerase II promoter [IDA]
- ureteric bud development [IMP]
- ventricular cardiac muscle cell differentiation [IMP]
Gene Ontology Molecular Function- DNA binding [IDA]
- RNA polymerase II regulatory region DNA binding [IDA]
- RNA polymerase II regulatory region sequence-specific DNA binding [IDA]
- chromatin DNA binding [ISO]
- drug binding [ISO]
- enzyme binding [ISO]
- histone deacetylase binding [ISO]
- ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [IDA]
- mRNA 5'-UTR binding [ISO]
- phosphatidylinositol 3-kinase regulator activity [ISO]
- protein binding [IPI]
- protein domain specific binding [ISO]
- protein heterodimerization activity [ISO]
- protein kinase A binding [ISO]
- protein kinase B binding [ISO]
- receptor binding [ISO]
- retinoic acid binding [ISO]
- retinoic acid receptor activity [IDA, ISO]
- retinoic acid-responsive element binding [ISO]
- sequence-specific DNA binding [IDA, IGI]
- sequence-specific DNA binding transcription factor activity [IDA, ISO]
- transcription coactivator activity [ISO]
- transcription corepressor activity [ISO]
- transcription factor binding [IPI, ISO]
- transcription regulatory region DNA binding [IMP]
- translation repressor activity, nucleic acid binding [ISO]
- DNA binding [IDA]
- RNA polymerase II regulatory region DNA binding [IDA]
- RNA polymerase II regulatory region sequence-specific DNA binding [IDA]
- chromatin DNA binding [ISO]
- drug binding [ISO]
- enzyme binding [ISO]
- histone deacetylase binding [ISO]
- ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [IDA]
- mRNA 5'-UTR binding [ISO]
- phosphatidylinositol 3-kinase regulator activity [ISO]
- protein binding [IPI]
- protein domain specific binding [ISO]
- protein heterodimerization activity [ISO]
- protein kinase A binding [ISO]
- protein kinase B binding [ISO]
- receptor binding [ISO]
- retinoic acid binding [ISO]
- retinoic acid receptor activity [IDA, ISO]
- retinoic acid-responsive element binding [ISO]
- sequence-specific DNA binding [IDA, IGI]
- sequence-specific DNA binding transcription factor activity [IDA, ISO]
- transcription coactivator activity [ISO]
- transcription corepressor activity [ISO]
- transcription factor binding [IPI, ISO]
- transcription regulatory region DNA binding [IMP]
- translation repressor activity, nucleic acid binding [ISO]
Gene Ontology Cellular Component
TCEB2
Gene Ontology Biological Process
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Reconstituted Complex
An interaction is inferred between proteins in vitro. This can include proteins in recombinant form or proteins isolated directly from cells with recombinant or purified bait. For example, GST pull-down assays where a GST-tagged protein is first isolated and then used to fish interactors from cell lysates are considered reconstituted complexes (e.g. PUBMED: 14657240, Fig. 4A or PUBMED: 14761940, Fig. 5). This can also include gel-shifts, surface plasmon resonance, isothermal titration calorimetry (ITC) and bio-layer interferometry (BLI) experiments. The bait-hit directionality may not be clear for 2 interacting proteins. In these cases the directionality is up to the discretion of the curator.
Publication
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families.
The Elongin BC complex was identified initially as a positive regulator of RNA polymerase II (Pol II) elongation factor Elongin A and subsequently as a component of the multiprotein von Hippel-Lindau (VHL) tumor suppressor complex, in which it participates in both tumor suppression and negative regulation of hypoxia-inducible genes. Elongin B is a ubiquitin-like protein, and Elongin C is a ... [more]
Throughput
- Low Throughput
Curated By
- BioGRID